Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.


Brevican is a member of the lectican family of chondroitin sulfate proteoglycans that is predominantly expressed in the central nervous system. The susceptibility of brevican to digestion by matrix metalloproteinases (MMP-1, -2, -3, -7, -8, -9, -10, and -13 and membrane type 1 and 3 MMPs) and aggrecanase-1 (ADAMTS4) was examined. MMP-1, -2, -3, -7, -8, -10, and -13 degraded brevican into a few fragments with similar molecular masses, whereas the degradation products of aggrecanase-1 had apparently different sizes. NH(2)-terminal sequence analyses of the digestion fragments revealed that cleavages of the brevican core protein by these metalloproteinases occurred commonly within the central non-homologous domain. MMP-1, -2, -3, -7, -8, -10, and -13 preferentially attacked the Ala(360)-Phe(361) bond, whereas aggrecanase-1 cleaved the Glu(395)-Ser(396) bond, which are similar to the cleavage sites observed with cartilage proteoglycan (aggrecan) for the MMPs and aggrecanase-1, respectively. These data demonstrate that MMP-1, -2, -3, -7, -8, -10, and -13 and aggrecanase-1 digest brevican in a similar pattern to aggrecan and suggest that they may be responsible for the physiological turnover and pathological degradation of brevican.

Citations per Year

1,243 Citations

Semantic Scholar estimates that this publication has 1,243 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Nakamura2000BrevicanID, title={Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.}, author={Hirotoshi Nakamura and Y Fujii and Isao Inoki and Koh-ichi Sugimoto and Kazuhiko Tanzawa and Hidenori Matsuki and Retsu Miura and Yasuka L. Yamaguchi and Yukio Okada}, journal={The Journal of biological chemistry}, year={2000}, volume={275 49}, pages={38885-90} }